09th February 2022 | Pharma Updates
Wockhardt to Export Sputnik V Vaccine
The drug company has received a nod from CDSCO to export up to 8 cr doses of Sputnik Light and 2 cr doses of Sputnik V Component I vaccines.
Hospitals witness less demand for Sputnik Light
DRL has sought authority approval to market and use Russia’s Sputnik Light as a booster dose.
Lupin receives green light from US FDA for generic drug
The generic version of arformoterol tartrate inhalation solution helps cure patients with COPD.
Biocon Pharma wins Approval for Posaconazole Delayed-Release tablets
With an intent to prevent fungal infection in immune-suppressed patients, the drugmaker will launch these tablets.
Old Drug to Protect Covid-19 Patients
Disulfiram showed efficacy in protecting rodents from lung injury in a recent preclinical study by researchers of Weill Cornell Medicine and Cold Spring Harbor Lab.
US's Drug Regulator Reevaluates Approvals for Umbralisib
FDA is now reevaluating the risks of Ukoniq against its benefits.
VCN-01 Gets Orphan Drug Designation for Retinoblastoma
VCN is developing an OV platform to address the unmet demands of tumour patients.
Maravai LifeSciences buys MyChem
The acquisition will expand Maravai Lifesciences’s offerings in vaccines and therapeutics.
Novasep's Chromatography Div Is Now Sartorius Part
The consolidated sales revenue of Sartorius Stedim Biotech is now expected to increase by around 15%-19%.
Vimian Group Acquires Vet-Allergy
Vimian Group has acquired a veterinary allergy company to strengthen its portfolio.
